As fibroblast-specific deletion of Ccn1 resulted in impaired collagen organization and neovascularization, we reasoned that CCN1-deficient stroma would enhance the ability of CD4+ T cells to penetrate tumor cells. The gene discussed is CCN1; the disease is neoplasm.